GENE EXPRESSION PROFILLING OF WHOLE BLOOD IN PATIENTS WITH SEVERE LEPTOSPIROSIS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210823003

Enrollment

Registered

2021-08-23

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Leptospirosis in patients. Leptospirosis, Severe leptospirosis, mRNA expression

Interventions

Patients diagnosed withLeptospirosis(confirmed by WHO

Diagnostic

Severe leptospirosis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Clinical symtom like leptospirosis include of fever, muscle pain and history of exposure foolding and rodent animals. 2.Confirmed Leptospirosis follow by WHO

Exclusion criteria

Exclusion criteria: Diagnosis other infectious

Design outcomes

Primary

Measure	Time frame
mRNA Expression Day on patient admit Nanostring technology	—

Secondary

Measure	Time frame
Predict severe leptospirosis Day on patient admit Relative expression by qRT-PCR	—

Countries

Thailand

Contacts

Public ContactNattachai Srisawat

Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital

drnattachai@yahoo.com0818361891

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026